Press Releases

At the ISHLT Annual Meeting in Boston, Dr. Jeffrey Teuteberg showed how molecular testing like cell-free DNA is reducing biopsies, personalizing post-transplant care, and improving outcomes through earlier rejection detection and easier remote monitoring.

At the ISHLT Annual Meeting in Boston, Jitte Jennekens shared that the HOPE technique safely preserves donor lungs outside the body for up to 20 hours. In a study of 12 HOPE cases, all lungs were successfully transplanted with outcomes matching traditional methods, showing promise for extended lung preservation.

At the ISHLT Annual Meeting in Boston, Dr. Angela Lorts stressed the need for pediatric-specific MCS devices, as current adult devices are used off-label for children, leading to safety concerns and supply issues. She introduced the ACTION Network to improve awareness and collaborate on better solutions.

Ten years after its introduction, heart donation after circulatory death (DCD) has significantly boosted transplant rates, with many centers reporting a 30% increase. Proven as effective as traditional methods, DCD is now widely adopted and continues to expand access to life-saving heart transplants.

A talk at the ISHLT2025 Annual Meeting given by Emily Granger, MBBS from St. Vincent’s Hospital in Sydney highlights how machine perfusion technology is revolutionizing heart transplantation in geographically vast countries like Australia.

A groundbreaking collaboration among leading organizations in pediatric heart transplantation has led to the formation of Pediatric Heart Transplant Alliance. Founding partners include Enduring Hearts, ISHLT, PHTS, Transplant Families, ACTION, and Additional Ventures.

At the ISHLT Annual Meeting, a dedicated ISHLT/ICA CTEPH conference spotlighted major advances in diagnosing and treating this often-misdiagnosed lung condition caused by chronic blood clots. Improved awareness and techniques are driving earlier detection and better outcomes.

Healthcare practitioners from around the world received hands-on training for treating patients in cardiogenic shock (CS) during a first-ever simulation lab at today’s Annual Meeting and Scientific Sessions of ISHLT in Boston.

The International Society for Heart and Lung Transplantation (ISHLT) announced $112,000 USD, funded by the ISHLT Foundation, in funding for research designed to improve care for patients with advanced heart and lung disease.

To address the need for a coordinated, multidisciplinary approach to patients transition from pediatric to adult healthcare systems, the International Society for Heart and Lung Transplantation (ISHLT) has launched a Pediatric to Adult Transition Task Force.